Neutrophil gene expression in chronic myeloproliferative disorders.

被引：0
|
作者：
Eagleton, HJ [1 ]
Pellagatti, A [1 ]
Campbell, L [1 ]
Littlewood, TJ [1 ]
Wainscoat, JS [1 ]
Boultwood, J [1 ]
机构：
[1] John Radcliffe Hosp, LRF Mol Haematol Unit, Oxford OX3 9DU, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4488
引用
收藏
页码：192B / 192B
页数：1
相关论文
共 50 条
  • [1] Thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Bas, B
    Köksal, A
    Özatli, D
    Haznedaroglu, I
    Büyükasik, Y
    Kosar, A
    Özcebe, O
    Sayinalp, N
    Dündar, S
    BLOOD, 1999, 94 (10) : 288B - 288B
  • [2] Increased angiogenesis in chronic myeloproliferative disorders.
    Willer, A
    Hastka, J
    La Rosée, P
    Saussele, S
    Reiter, A
    Kuhn, C
    Hochhaus, A
    Hehlmann, R
    BLOOD, 2000, 96 (11) : 748A - 748A
  • [3] Allogeneic marrow transplantation for chronic myeloproliferative disorders.
    Przepiorka, D
    Giralt, S
    Khouri, I
    Champlin, R
    BuesoRamos, C
    BLOOD, 1997, 90 (10) : 4509 - 4509
  • [4] Chronic myeloproliferative disorders. The new WHO classification
    Thiele, J
    Kvasnicka, HM
    PATHOLOGE, 2001, 22 (06): : 429 - 443
  • [5] Differences in PRV-1 expression among patients with chronic myeloproliferative disorders.
    Bellosillo, B
    Besses, C
    Florensa, L
    Zamora, L
    Espinet, B
    Abella, E
    Salar, A
    Musset, M
    Longaron, R
    Vela, MC
    Woessner, S
    Serrano, S
    Sole, FS
    BLOOD, 2003, 102 (11) : 664A - 664A
  • [6] Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.
    Gupta, R
    Perumandla, S
    Patsiornik, Y
    Niranjan, S
    Ohri, A
    BLOOD, 2005, 106 (11) : 314B - 314B
  • [7] Clonality in myeloproliferative disorders.
    Gregg, XT
    Liu, Y
    Prchal, JT
    Gartland, GL
    Cooper, MD
    Prchal, JF
    BLOOD, 1996, 88 (10) : 1905 - 1905
  • [8] Anagrelide in the treatment of thrombocytosis in patients with chronic myeloproliferative disorders.
    Mazur, G
    Wrobel, T
    Kuliszkiewiez-Janus, M
    Podolak-Dawidziak, M
    Potoczek, S
    Nosol, J
    Kuliczkowski, K
    BLOOD, 2003, 102 (11) : 342B - 342B
  • [9] Quantitative evaluation of granulocyte PRV-1 mRNA expression in chronic myeloproliferative disorders.
    Passamonti, F
    Pietra, D
    Rumi, E
    Malabarba, L
    Vanelli, L
    Marseglia, C
    Malcovati, L
    Bonfichi, M
    Orlandi, E
    Pascutto, C
    Lazzarino, M
    Cazzola, M
    BLOOD, 2003, 102 (11) : 662A - 663A
  • [10] Adhesion molecules expression and possible latent endothelial cell dysfunction in chronic myeloproliferative disorders.
    Stagno, F
    Cultrera, D
    Santonocito, AM
    Privitera, A
    Parisi, G
    Pavone, B
    Salemi, S
    Consoli, U
    Giustolisi, G
    Guglielmo, P
    Musso, R
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 43 - 43
12345